Quayside Holdings takes large stake in medical honey company
HoneyLab set to sign deal with global consumer pharmaceutical company. With special feature audio.
The Bay of Plenty Regional Council’s investment arm Quayside Holdings has taken a 25% stake in healthcare company HoneyLab, which is set to sign with a global consumer pharmaceutical company to license its patented technology.
HoneyLab develops medical products for skin conditions, pain, nutrition
Want to read more? It's easy.
Choose your best value subscription option
Individual
Group membership
NBR Marketplace
Yearly Premium Online Subscription
NZ$499.00 / yearly
Monthly Premium Online Subscription
NZ$44.95 / monthly
Smartphone Only Subscription
NZ$24.95 / monthly
Premium Group Membership 10 Users
NZ$350+GST / monthly
$35 per user - Pay by monthly credit card debitPremium Group Membership 20 Users
NZ$600+GST / monthly
$30 per user - Pay by monthly credit card debitPremium Group Membership 50 Users
NZ$1250+GST / monthly
$25 per user - Pay by monthly credit card debitPremium Group Membership 100 Users
NZ$1875+GST / monthly
$18.75 per user - Pay by monthly credit card debitYearly Premium Online Subscription + NBR Marketplace
NZ$499.00 / yearly
Already have an account? Login
Calida Smylie
Fri, 24 Jun 2016
Fri, 24 Jun 2016
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Quayside Holdings takes large stake in medical honey company
59343